105 related articles for article (PubMed ID: 1517164)
1. Isolation and identification of new anthracycline antibiotics, rubomycins F and H.
Fomichova EV; Fedorova GB; Potapova NP; Katrukha GS
J Antibiot (Tokyo); 1992 Jul; 45(7):1185-6. PubMed ID: 1517164
[No Abstract] [Full Text] [Related]
2. [Isolation and evaluation of the structure of the new anthracycline antibiotics rubomycins F and H].
Fomicheva EV; Fedorova GB; Potapova NP; Katrukha GS
Antibiot Khimioter; 1992 Aug; 37(8):27-9. PubMed ID: 1456819
[TBL] [Abstract][Full Text] [Related]
3. Baumycin analogs isolated from Actinomadura sp.
Matsuzawa Y; Yoshimoto A; Kouno K; Oki T
J Antibiot (Tokyo); 1981 Jun; 34(6):774-6. PubMed ID: 7053087
[No Abstract] [Full Text] [Related]
4. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5.
Yoshimoto A; Fujii S; Johdo O; Kubo K; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1993 Jan; 46(1):56-64. PubMed ID: 8436560
[TBL] [Abstract][Full Text] [Related]
5. A new anthracycline antibiotic SN-706.
Kimura K; Koyama T; Nakayama S; Tamura K; Miyata N; Kawanishi G
J Antibiot (Tokyo); 1988 Dec; 41(12):1918-21. PubMed ID: 3209485
[No Abstract] [Full Text] [Related]
6. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. III. New anthracycline metabolites produced by blocked mutants 4L-660 and YDK-18.
Yoshimoto A; Johdo O; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1993 Nov; 46(11):1758-61. PubMed ID: 8270500
[No Abstract] [Full Text] [Related]
7. A new anthracycline metabolite D788-1 (10-carboxy-13-deoxocarminomycin) in daunorubicin beer.
Fujii S; Kubo K; Johdo O; Yoshimoto A; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Mar; 39(3):473-5. PubMed ID: 3700249
[No Abstract] [Full Text] [Related]
8. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization.
Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T
J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846
[TBL] [Abstract][Full Text] [Related]
9. [Derivatives of daunorubicin containing an inosine fragment].
Olsuf'eva EN; Todorova NP; Iartseva IV; Rozynov BV; Shepelevtseva NG; Preobrazhenskaia MN
Bioorg Khim; 1989 Nov; 15(11):1569-72. PubMed ID: 2624594
[TBL] [Abstract][Full Text] [Related]
10. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
[No Abstract] [Full Text] [Related]
11. Inhibition of topoisomerase I by anthracycline antibiotics: evidence for general inhibition of topoisomerase I by DNA-binding agents.
Crow RT; Crothers DM
J Med Chem; 1994 Sep; 37(19):3191-4. PubMed ID: 7932544
[TBL] [Abstract][Full Text] [Related]
12. Induction of prophage lambda by daunorubicin and derivatives correlation with antineoplastic activity.
Anderson WA; Moreau PL; Devoret R; Maral R
Mutat Res; 1980 Mar; 77(3):197-208. PubMed ID: 6446038
[TBL] [Abstract][Full Text] [Related]
13. The method of daunorubicin purification.
Sławiński W; Oszczapowicz I; Cichocka K; Zimniak A
Acta Pol Pharm; 2001; 58(4):263-8. PubMed ID: 11693730
[TBL] [Abstract][Full Text] [Related]
14. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
15. Baumycins, new antitumor antibiotics related to daunomycin.
Komiyana T; Matsuzawa Y; Oki T; Inui T; Takahashi Y; Naganawa H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1977 Jul; 30(7):619-21. PubMed ID: 561047
[No Abstract] [Full Text] [Related]
16. Biologic activity of adriamycin (NSC-123127) in microbial systems.
Pittillo RF; Woolley C
Cancer Chemother Rep; 1971 Jun; 55(3):221-7. PubMed ID: 5000531
[No Abstract] [Full Text] [Related]
17. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
Babudri N; Pani B; Tamaro M; Monti-Bragadin C; Zunino F
Br J Cancer; 1984 Jul; 50(1):91-6. PubMed ID: 6378238
[TBL] [Abstract][Full Text] [Related]
18. A new antitumor antibiotic, kidamycin. I. Isolation, purification and properties of kidamycin.
Kanda N
J Antibiot (Tokyo); 1971 Sep; 24(9):599-606. PubMed ID: 5132247
[No Abstract] [Full Text] [Related]
19. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I
Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.
Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T
J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
